DexCom (DXCM) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

DexCom (DXCM) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 16, 2024 (06:38)

Sector: Healthcare

The share price of DexCom, Inc. (DXCM) now

Latest session on the 15th of April for
DexCom, Inc. is negative
Trading Volume: 2553508
Open: 137.81 /  High: 138.015 /  Low: 134.5
What analysts predict: $150.59
52-week High/Low: $142 / $74.75

50/200 Day Moving Average: $126.95 / $114.58

This figure corresponds to the Average Price over the previous 50/200 days. For DexCom stocks, the 50-day moving average is the support level today.

For DexCom stocks, the 200-day moving average is the support level today.

Are you interested in DexCom, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the DexCom stock price in 2024, 2025, 2026, 2027, 2028. How much will one DexCom share be worth in 2024 - 2028?

When should I take profit in DexCom stock? When should I record a loss on DexCom stock? What are analysts' forecasts for DexCom stock? What is the future of DexCom stock? We forecast DexCom stock performance using neural networks based on historical data on DexCom stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

DexCom stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for DexCom shares. This happens once a day.


Historical and forecast chart of DexCom stock

The chart below shows the historical price of DexCom stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the DexCom stock price can be found in the table below.

Long-term forecasts by years.

Dexcom, Inc. is a medical equipment company. The company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare professionals. Its products include Dexcom G6 and Dexcom stake. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which can include automated insulin dosing systems, insulin pumps, blood glucose meters, or other electronic devices used to treat diabetes. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on a patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transfer glucose information to the cloud and then to apps on mobile devices to up to five designated recipients who can remotely monitor patient glucose information and receive alerts.

DexCom daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 18 141.04 138.43 141.87 2.48
Apr 19 141.28 140.37 143.73 2.40
Apr 20 140.68 139.78 143.28 2.51
Apr 21 140.92 138.71 143.01 3.10
Apr 22 141.51 139.21 143.14 2.82
Apr 23 143.33 140.97 145.42 3.16
Apr 24 143.94 141.44 144.82 2.39
Apr 25 143.53 142.61 146.15 2.48
Apr 26 144.02 142.12 146.52 3.09
Apr 27 140.39 139.05 141.76 1.95
Apr 28 142.20 140.68 142.99 1.64
Apr 29 142.43 140.20 144.19 2.84
Apr 30 141.76 138.58 144.69 4.41
May 01 144.85 142.58 145.66 2.16
May 02 147.20 143.95 148.23 2.98
May 03 147.00 146.05 148.52 1.69
May 04 150.29 147.18 152.52 3.63
May 05 151.76 150.62 153.63 2.00
May 06 151.08 150.11 151.97 1.24
May 07 148.08 145.51 151.15 3.88
May 08 146.75 145.15 149.47 2.97
May 09 143.43 141.70 146.00 3.03
May 10 144.99 144.06 146.74 1.86
May 11 145.48 142.99 148.66 3.96
May 12 146.90 144.15 148.84 3.25
May 13 149.99 146.71 150.96 2.89
May 14 148.94 147.06 151.61 3.09
May 15 149.48 147.97 152.29 2.91
May 16 148.81 147.69 151.60 2.65
May 17 148.31 146.40 151.01 3.15

DexCom Daily Price Targets


DexCom Stock Forecast 04-18-2024.

Forecast target price for 04-18-2024: $141.04.
Positive dynamics for DexCom shares will prevail with possible volatility of 2.421%.
Pessimistic target level: 138.43
Optimistic target level: 141.87

DexCom Stock Forecast 04-19-2024.

Forecast target price for 04-19-2024: $141.28.
Positive dynamics for DexCom shares will prevail with possible volatility of 2.340%.
Pessimistic target level: 140.37
Optimistic target level: 143.73

DexCom Stock Forecast 04-20-2024.

Forecast target price for 04-20-2024: $140.68.
Negative dynamics for DexCom shares will prevail with possible volatility of 2.446%.
Pessimistic target level: 139.78
Optimistic target level: 143.28

DexCom Stock Forecast 04-21-2024.

Forecast target price for 04-21-2024: $140.92.
Positive dynamics for DexCom shares will prevail with possible volatility of 3.007%.
Pessimistic target level: 138.71
Optimistic target level: 143.01

DexCom Stock Forecast 04-22-2024.

Forecast target price for 04-22-2024: $141.51.
Positive dynamics for DexCom shares will prevail with possible volatility of 2.740%.
Pessimistic target level: 139.21
Optimistic target level: 143.14

DexCom Stock Forecast 04-23-2024.

Forecast target price for 04-23-2024: $143.33.
Positive dynamics for DexCom shares will prevail with possible volatility of 3.063%.
Pessimistic target level: 140.97
Optimistic target level: 145.42

DXCM (DXCM) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 148.88 143.40 156.62 8.44
Jun. 146.97 140.15 153.67 8.80
Jul. 146.85 140.16 151.32 7.38
Aug. 138.63 134.08 147.06 8.82
Sep. 131.09 126.89 138.12 8.12
Oct. 134.34 132.08 141.97 6.96
Nov. 135.52 131.40 139.43 5.75
Dec. 137.69 129.43 146.17 11.45

DexCom forecast for this year


DexCom Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $148.877. Pessimistic: $143.40. Optimistic: $156.62


DexCom Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $146.971. Pessimistic: $140.15. Optimistic: $153.67


DexCom Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $146.854. Pessimistic: $140.16. Optimistic: $151.32


DexCom Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $138.63. Pessimistic: $134.08. Optimistic: $147.06


DexCom Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $131.089. Pessimistic: $126.89. Optimistic: $138.12


DexCom Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $134.34. Pessimistic: $132.08. Optimistic: $141.97


DexCom Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $135.522. Pessimistic: $131.40. Optimistic: $139.43


DexCom Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $137.69. Pessimistic: $129.43. Optimistic: $146.17



DexCom (DXCM) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 139.01 132.23 141.24 6.38
Feb 140.35 136.42 143.38 4.85
Mar 141.36 135.93 144.07 5.65
Apr 131.29 126.15 139.38 9.49
May 128.25 122.60 133.48 8.15
Jun 129.58 122.32 133.42 8.31
Jul 134.66 132.29 143.28 7.67
Aug 134.12 128.33 136.80 6.20
Sep 140.24 137.77 147.75 6.76
Oct 142.93 139.84 146.13 4.30
Nov 145.79 138.91 150.10 7.46
Dec 144.51 139.42 147.86 5.71

DexCom (DXCM) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 142.42 133.31 148.24 10.07
Feb 138.55 133.23 141.88 6.09
Mar 140.88 132.43 147.75 10.37
Apr 141.22 133.31 144.04 7.45
May 135.68 128.41 138.83 7.51
Jun 130.25 125.77 134.00 6.14
Jul 135.46 131.78 141.21 6.68
Aug 133.08 125.73 139.15 9.64
Sep 131.70 127.69 139.60 8.53
Oct 135.91 130.04 139.39 6.71
Nov 127.10 122.63 131.37 6.66
Dec 122.32 120.37 125.46 4.06

DexCom (DXCM) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 128.29 124.39 133.42 6.77
Feb 135.48 131.25 140.79 6.77
Mar 134.94 131.48 139.69 5.87
Apr 137.63 131.69 141.05 6.64
May 139.62 131.46 143.64 8.48
Jun 145.09 141.14 148.69 5.07
Jul 139.52 135.05 143.42 5.84
Aug 141.30 136.67 145.15 5.84
Sep 132.94 129.96 135.92 4.38
Oct 134.11 131.64 138.83 5.18
Nov 128.74 122.98 131.32 6.35
Dec 135.23 131.55 142.16 7.46

DexCom (DXCM) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 145.94 143.02 154.93 7.69
Feb 148.86 143.15 154.34 7.25
Mar 154.58 144.93 157.30 7.86
Apr 153.71 148.42 159.74 7.08
May 150.52 145.58 158.58 8.20
Jun 160.51 152.03 165.13 7.93
Jul 166.29 163.36 175.73 7.04
Aug 153.78 149.97 160.80 6.73
Sep 153.91 145.04 157.23 7.75
Oct 155.75 151.64 163.48 7.24
Nov 150.52 147.51 153.53 3.92
Dec 146.43 142.56 149.59 4.70

DexCom information and performance

DexCom Address

6340 SEQUENCE DRIVE, SAN DIEGO, CA, US

Market Capitalization: 53 948 973 000 $

Market capitalization of the DexCom, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DXCM shares in the company outstanding by the market price of one share.

EBITDA: 783 700 000 $

EBITDA of DexCom is earnings before interest, income tax and depreciation of assets.

PE Ratio: 107.65

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.602

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.3

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 1.81
Quarterly Revenue Growth YOY: 0.269
Trailing PE: 107.65

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 80

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 14.86

Enterprise Value (EV) /Revenue

EV To EBITDA: 58.72

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 385515000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.